No7No7 Serum Smoothing Facial Treatment

BUY at Target

Introducing the New non-invasive wrinkle solution. Clinically proven to reduce the appearance of wrinkles by up to 5 years in 12 weeks. This clinically proven, targeted booster serum is our most concentrated line correcting serum, specially designed to be applied directly to lines and wrinkles. - Formulated with a highly concentrated amount of Matrixyl 3000+, No7's powerful anti-wrinkle peptide technology from our clinically proven serums. Results - In 1 week, women saw a visible reduction in the appearance of lines and wrinkles on the forehead and around the eyes. - By 2 weeks, women saw visible improvements in 6 targeted wrinkle areas (1. Forehead, 2. Crow's feet, 3. Lip, 4. Between brows 5, Under eyes and Nasolabial folds). Finally, an alternative to injections that directly targets lines and wrinkles. - Among women who were considering injectables[1], after trialing the product for 2 months, 77 percent of women said the serum gave them better results than they thought possible from skincare and 73 percent said they were less likely to consider injectables in the future. - Of those that had already had injectables[1], 80 percent of women said the serum gave them better results than they thought possible from skincare and 73 percent said they would delay their next treatment. Proven to visibly reduce the appearance of even the deepest, most stubborn lines and wrinkles. Suitable for all skin types: Normal, oily, combination or dry. How To Use: Twist silver base to unlock and then press to dispense desired amount. Apply directly to lines and wrinkles every morning and evening before applying your usual No7 serum and moisturizer. [1] Tested on 81 women in a consumer study considering injectables and 30 women who have had injectables over 8 weeks. Ingredients: Aqua (Water), Glycerin, Butylene Glycol, Aluminium Starch Octenylsuccinate, Polyacrylate Crosspolymer-6, Sorbitan Laurate, Phenoxyethnaol, Sodium Lactate, Hydroxyethylcelulose, Carbomer, Caprylyl Glycol, Ace...